Pharma Reviews: Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer

The Indian pharma market stood at Rs 121,833 crore at the end of financial year 2018, growing at 6.3 per cent over the last 12 months period.
Read more: Price control, ad-hoc regulatory changes may hamper pharma sector growth: Pfizer